263 related articles for article (PubMed ID: 14581375)
21. Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells.
Cano-Soldado P; Molina-Arcas M; Algueró B; Larráyoz I; Lostao MP; Grandas A; Casado FJ; Pastor-Anglada M
Biochem Pharmacol; 2008 Feb; 75(3):639-48. PubMed ID: 18053967
[TBL] [Abstract][Full Text] [Related]
22. Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1.
Graham KA; Leithoff J; Coe IR; Mowles D; Mackey JR; Young JD; Cass CE
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):415-34. PubMed ID: 10772724
[TBL] [Abstract][Full Text] [Related]
23. The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy.
Lane J; Martin TA; McGuigan C; Mason MD; Jiang WG
J Exp Ther Oncol; 2010; 8(3):203-10. PubMed ID: 20734919
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells.
Avan A; Crea F; Paolicchi E; Funel N; Galvani E; Marquez VE; Honeywell RJ; Danesi R; Peters GJ; Giovannetti E
Mol Cancer Ther; 2012 Aug; 11(8):1735-46. PubMed ID: 22622284
[TBL] [Abstract][Full Text] [Related]
25. Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells.
Hagmann W; Jesnowski R; Löhr JM
Neoplasia; 2010 Sep; 12(9):740-7. PubMed ID: 20824050
[TBL] [Abstract][Full Text] [Related]
26. The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2.
Skrypek N; Vasseur R; Vincent A; Duchêne B; Van Seuningen I; Jonckheere N
Oncotarget; 2015 May; 6(13):10853-67. PubMed ID: 25890497
[TBL] [Abstract][Full Text] [Related]
27. Enhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1.
Wang H; Word BR; Lyn-Cook BD
Anticancer Res; 2011 Oct; 31(10):3171-80. PubMed ID: 21965724
[TBL] [Abstract][Full Text] [Related]
28. Human concentrative nucleoside transporter 3 transfection with ultrasound and microbubbles in nucleoside transport deficient HEK293 cells greatly increases gemcitabine uptake.
Paproski RJ; Yao SY; Favis N; Evans D; Young JD; Cass CE; Zemp RJ
PLoS One; 2013; 8(2):e56423. PubMed ID: 23441192
[TBL] [Abstract][Full Text] [Related]
29. Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity.
Rauchwerger DR; Firby PS; Hedley DW; Moore MJ
Cancer Res; 2000 Nov; 60(21):6075-9. PubMed ID: 11085530
[TBL] [Abstract][Full Text] [Related]
30. Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors.
Farré X; Guillén-Gómez E; Sánchez L; Hardisson D; Plaza Y; Lloberas J; Casado FJ; Palacios J; Pastor-Anglada M
Int J Cancer; 2004 Dec; 112(6):959-66. PubMed ID: 15386342
[TBL] [Abstract][Full Text] [Related]
31. Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine.
Damaraju VL; Mowles D; Yao S; Ng A; Young JD; Cass CE; Tong Z
Nucleosides Nucleotides Nucleic Acids; 2012; 31(3):236-55. PubMed ID: 22356238
[TBL] [Abstract][Full Text] [Related]
32. Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.
Farrell JJ; Elsaleh H; Garcia M; Lai R; Ammar A; Regine WF; Abrams R; Benson AB; Macdonald J; Cass CE; Dicker AP; Mackey JR
Gastroenterology; 2009 Jan; 136(1):187-95. PubMed ID: 18992248
[TBL] [Abstract][Full Text] [Related]
33. Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner.
Pérez-Torras S; Vidal-Pla A; Cano-Soldado P; Huber-Ruano I; Mazo A; Pastor-Anglada M
Cell Death Dis; 2013 May; 4(5):e648. PubMed ID: 23722537
[TBL] [Abstract][Full Text] [Related]
34. Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.
Giovannetti E; Del Tacca M; Mey V; Funel N; Nannizzi S; Ricci S; Orlandini C; Boggi U; Campani D; Del Chiaro M; Iannopollo M; Bevilacqua G; Mosca F; Danesi R
Cancer Res; 2006 Apr; 66(7):3928-35. PubMed ID: 16585222
[TBL] [Abstract][Full Text] [Related]
35. Correlation of nucleoside and nucleobase transporter gene expression with antimetabolite drug cytotoxicity.
Lu X; Gong S; Monks A; Zaharevitz D; Moscow JA
J Exp Ther Oncol; 2002; 2(4):200-12. PubMed ID: 12416024
[TBL] [Abstract][Full Text] [Related]
36. Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.
Jaramillo AC; Hubeek I; Broekhuizen R; Pastor-Anglada M; Kaspers GJL; Jansen G; Cloos J; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1379-1388. PubMed ID: 32312148
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous expression of hCNT1-CFP and hENT1-YFP in Madin-Darby canine kidney cells. Localization and vectorial transport studies.
Lai Y; Bakken AH; Unadkat JD
J Biol Chem; 2002 Oct; 277(40):37711-7. PubMed ID: 12097333
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of human equilibrative nucleoside transporter-1 (hENT1) predicts survival in resected pancreatic cancer patients treated with adjuvant gemcitabine monotherapy.
Morinaga S; Nakamura Y; Watanabe T; Mikayama H; Tamagawa H; Yamamoto N; Shiozawa M; Akaike M; Ohkawa S; Kameda Y; Miyagi Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S558-64. PubMed ID: 21913012
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer.
Ohhashi S; Ohuchida K; Mizumoto K; Fujita H; Egami T; Yu J; Toma H; Sadatomi S; Nagai E; Tanaka M
Anticancer Res; 2008; 28(4B):2205-12. PubMed ID: 18751396
[TBL] [Abstract][Full Text] [Related]
40. Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes.
Lostao MP; Mata JF; Larrayoz IM; Inzillo SM; Casado FJ; Pastor-Anglada M
FEBS Lett; 2000 Sep; 481(2):137-40. PubMed ID: 10996312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
